Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
31.50
-0.50 (-1.56%)
At close: Nov 28, 2025

Mega Lifesciences PCL Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
1,9742,0121,9932,2421,9471,393
Upgrade
Depreciation & Amortization
278.98277.74279.98265.18268.86250.98
Upgrade
Other Amortization
5.695.695.896.835.575.35
Upgrade
Loss (Gain) From Sale of Assets
-5.02-2.65-2.87-2.08-3.510.51
Upgrade
Asset Writedown & Restructuring Costs
-0.66-0.59-0.548.5928.02-
Upgrade
Loss (Gain) on Equity Investments
0.25-0.15-0.07-0.181.5145.52
Upgrade
Provision & Write-off of Bad Debts
2.613.6812.175.833.092.18
Upgrade
Other Operating Activities
157.95251.64238.7270.439.8127.31
Upgrade
Change in Accounts Receivable
-136.41231.3-322.23-631.4718.0268.51
Upgrade
Change in Inventory
32.64447.19569.37-576.69-273.63-602.17
Upgrade
Change in Accounts Payable
-63.64-278.66-885.27364.68375.6848.44
Upgrade
Change in Other Net Operating Assets
267.98-546.2838.65243.99316.59290.15
Upgrade
Operating Cash Flow
2,5152,4011,9261,9972,7271,629
Upgrade
Operating Cash Flow Growth
27.90%24.65%-3.51%-26.78%67.35%8.98%
Upgrade
Capital Expenditures
-485.14-247.53-274.65-304.6-151.4-234.43
Upgrade
Sale of Property, Plant & Equipment
4.0717.724.532.866.474.04
Upgrade
Cash Acquisitions
----9.25--410.56
Upgrade
Sale (Purchase) of Intangibles
-8.39-9.76-18.93-8.14-8.38-20.64
Upgrade
Investment in Securities
-344.81178.14-20.11-1.75-122.570.62
Upgrade
Other Investing Activities
64.9762.8759.1440.0711.1910.68
Upgrade
Investing Cash Flow
-769.291.45-250.01-280.83-264.68-650.28
Upgrade
Short-Term Debt Issued
-215.37-65.2--
Upgrade
Total Debt Issued
282.27215.37-65.2--
Upgrade
Short-Term Debt Repaid
---148.66--309.49-432.03
Upgrade
Long-Term Debt Repaid
--60.16-88.6-58.1-53.52-55.54
Upgrade
Total Debt Repaid
-62.58-60.16-237.26-58.1-363.01-487.57
Upgrade
Net Debt Issued (Repaid)
219.69155.21-237.267.1-363.01-487.57
Upgrade
Common Dividends Paid
-1,395-1,395-1,439-1,406-922.94-670.19
Upgrade
Other Financing Activities
-46.95-38.04-31.75-34.76-27.93-64.63
Upgrade
Financing Cash Flow
-1,222-1,277-1,708-1,433-1,314-1,222
Upgrade
Foreign Exchange Rate Adjustments
-9.63-19.42-64.92-26.7642.981.77
Upgrade
Net Cash Flow
513.971,106-96.74255.771,191-241.47
Upgrade
Free Cash Flow
2,0302,1541,6521,6922,5751,395
Upgrade
Free Cash Flow Growth
19.23%30.39%-2.38%-34.30%84.62%44.32%
Upgrade
Free Cash Flow Margin
14.30%14.00%10.51%10.76%18.17%11.06%
Upgrade
Free Cash Flow Per Share
2.332.471.901.942.951.60
Upgrade
Cash Interest Paid
46.9538.0431.7529.8527.9364.63
Upgrade
Cash Income Tax Paid
385.89362.3423.09389.5362.76227.43
Upgrade
Levered Free Cash Flow
2,0432,2891,4131,2091,989864.17
Upgrade
Unlevered Free Cash Flow
2,0752,3141,4331,2272,006909.34
Upgrade
Change in Working Capital
100.56-146.45-599.47-599.49436.66-195.08
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.